ArticleNPJ breast cancer2021

Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST?

Mary Kathryn Abel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.